Cargando…
An inhibitor of BRD4, GNE987, inhibits the growth of glioblastoma cells by targeting C-Myc and S100A16
PURPOSE: Among children, glioblastomas (GBMs) are a relatively common type of brain tumor. BRD4 expression was elevated in GBM and negatively correlated with the prognosis of glioma. We investigated the anti-GBM effects of a novel BRD4 inhibitor GNE987. METHODS: We evaluated the anti-tumor effect of...
Autores principales: | Ma, Liya, Li, Gen, Yang, Tianquan, Zhang, Li, Wang, Xinxin, Xu, Xiaowen, Ni, Hong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9637061/ https://www.ncbi.nlm.nih.gov/pubmed/36224471 http://dx.doi.org/10.1007/s00280-022-04483-7 |
Ejemplares similares
-
BRD4 inhibitor GNE987 exerts anti-cancer effects by targeting super-enhancers in neuroblastoma
por: Chen, Yan-Ling, et al.
Publicado: (2022) -
BRD4 Inhibitor GNE-987 Exerts Anticancer Effects by Targeting Super-Enhancer-Related Gene LYL1 in Acute Myeloid Leukemia
por: Sang, Xu, et al.
Publicado: (2022) -
Native Mass Spectrometry for the Study of PROTAC GNE‐987‐Containing Ternary Complexes
por: Sternicki, Louise M., et al.
Publicado: (2021) -
GNE genotype explains 20% of phenotypic variability in GNE myopathy
por: Pogoryelova, Oksana, et al.
Publicado: (2019) -
The BRD4 inhibitor JQ1 suppresses tumor growth by reducing c-Myc expression in endometrial cancer
por: Pang, Yingxin, et al.
Publicado: (2022)